Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.

Clinical trial NCT03172117 · COMPLETED

Trial details

NCT number: NCT03172117
Sponsor: Medipost Co Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2017-05-19
Primary completion: 2022-03-18
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.